Dr. Bennett spent eight years at the University of Miami before attending New York University. She ultimately returned to ...

On Feb. 27, 2025, Zevra entered into an asset purchase agreement for the sale of a Rare Pediatric Disease Priority Review Voucher (PRV), issued by the U.S. FDA upon the approval of MIPLYFFA, for $150 ...